Health Canada announces review of all MDMA trials, as complaint alleges major flaws and safety issues

Concerns about patient safety, reports of increased suicidal thinking and allegations of flawed research are at the heart of a new complaint to Health Canada over the much-hyped clinical trials for the use of MDMA to treat post-traumatic stress disorder.

from CBC | Health News https://ift.tt/BLrAonl